Cargando…
Retracted: Application Value of Combined Detection of Anti-β2-GPI, ACL, and Lupus Anticoagulant in the Diagnosis of Patients with Antiphospholipid Syndrome
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371539/ https://www.ncbi.nlm.nih.gov/pubmed/37501879 http://dx.doi.org/10.1155/2023/9873756 |
| _version_ | 1785078168846073856 |
|---|---|
| author | and Alternative Medicine, Evidence-Based Complementary |
| author_facet | and Alternative Medicine, Evidence-Based Complementary |
| author_sort | and Alternative Medicine, Evidence-Based Complementary |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10371539 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Hindawi |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103715392023-07-27 Retracted: Application Value of Combined Detection of Anti-β2-GPI, ACL, and Lupus Anticoagulant in the Diagnosis of Patients with Antiphospholipid Syndrome and Alternative Medicine, Evidence-Based Complementary Evid Based Complement Alternat Med Retraction Hindawi 2023-07-19 /pmc/articles/PMC10371539/ /pubmed/37501879 http://dx.doi.org/10.1155/2023/9873756 Text en Copyright © 2023 Evidence-Based Complementary and Alternative Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Retraction and Alternative Medicine, Evidence-Based Complementary Retracted: Application Value of Combined Detection of Anti-β2-GPI, ACL, and Lupus Anticoagulant in the Diagnosis of Patients with Antiphospholipid Syndrome |
| title | Retracted: Application Value of Combined Detection of Anti-β2-GPI, ACL, and Lupus Anticoagulant in the Diagnosis of Patients with Antiphospholipid Syndrome |
| title_full | Retracted: Application Value of Combined Detection of Anti-β2-GPI, ACL, and Lupus Anticoagulant in the Diagnosis of Patients with Antiphospholipid Syndrome |
| title_fullStr | Retracted: Application Value of Combined Detection of Anti-β2-GPI, ACL, and Lupus Anticoagulant in the Diagnosis of Patients with Antiphospholipid Syndrome |
| title_full_unstemmed | Retracted: Application Value of Combined Detection of Anti-β2-GPI, ACL, and Lupus Anticoagulant in the Diagnosis of Patients with Antiphospholipid Syndrome |
| title_short | Retracted: Application Value of Combined Detection of Anti-β2-GPI, ACL, and Lupus Anticoagulant in the Diagnosis of Patients with Antiphospholipid Syndrome |
| title_sort | retracted: application value of combined detection of anti-β2-gpi, acl, and lupus anticoagulant in the diagnosis of patients with antiphospholipid syndrome |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371539/ https://www.ncbi.nlm.nih.gov/pubmed/37501879 http://dx.doi.org/10.1155/2023/9873756 |
| work_keys_str_mv | AT andalternativemedicineevidencebasedcomplementary retractedapplicationvalueofcombineddetectionofantib2gpiaclandlupusanticoagulantinthediagnosisofpatientswithantiphospholipidsyndrome |